Jeong-yeol S. Park
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
Major clinical advances in gynecologic cancer in 2025: from de-escalation strategies to precision therapies beyond BRCA.
Journal: Journal of gynecologic oncology
Published: January 09, 2026
Maintenance of PARP Inhibitor Rechallenge plus Bevacizumab in Patients with Platinum-Sensitive, Recurrent Ovarian Cancer Previously Treated with a PARP Inhibitor.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 04, 2025
Sentinel Lymph Node Mapping Versus Systemic Lymphadenectomy in High-Risk Endometrial Cancer Patients: A Meta-Analysis of Oncologic Outcomes.
Journal: Journal of minimally invasive gynecology
Published: July 30, 2025
Phase II randomized study of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab alone or with nesuparib, in mismatch-repair proficient, advanced or recurrent endometrial cancer (PENELOPE).
Journal: Journal of gynecologic oncology
Published: July 16, 2025
Surgical time in gynecologic surgery using laparoscopic articulated instruments (KGOG 4002).
Journal: Obstetrics & gynecology science
Published: March 19, 2025
Asian Society of Gynecologic Oncology (ASGO) 2024 Annual Meeting in Bali, Indonesia.
Journal: Journal of gynecologic oncology
Published: February 20, 2025
Author's reply to: Cisplatin versus carboplatin?
Journal: Journal of gynecologic oncology
Published: February 16, 2025
Hemostatic Efficacy of TachoSil in Loop Electrosurgical Excisional Procedure: A Prospective Randomized Controlled Study.
Journal: Journal of lower genital tract disease
Published: January 22, 2025
Gynecologic oncology in 2024: breakthrough trials and evolving treatment strategies for cervical, uterine corpus, and ovarian cancers.
Journal: Journal of gynecologic oncology
Published: January 10, 2025
Real-world efficacy and toxicity of olaparib maintenance therapy in Korean ovarian cancer patients with an exploratory analysis of BRCA mutations.
Journal: Gynecologic oncology
Published: November 06, 2024
Comparison of single-site and three-port hysterectomy for benign uterine diseases: A randomised trial (LESS-H).
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: November 03, 2024
Last Updated: 09/26/2026